Zhangzhou Pien Tze Huang Pharmaceutical saw no growth in patent filings in April and highest growth of 0.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.32%. GlobalData’s DataBook provides a comprehensive analysis of Zhangzhou Pien Tze Huang Pharmaceutical’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Zhangzhou Pien Tze Huang Pharmaceutical has been focused on protecting inventions in Spain(ES) with two publications in Q2 2024
The Spain(ES) Patent Office dominates the patent grants with nearly 100% of grants. The Spain(ES) patent Office are among the top ten patent offices where Zhangzhou Pien Tze Huang Pharmaceutical is filings its patents. Among the top granted patent authorities, Zhangzhou Pien Tze Huang Pharmaceutical has 100% of its grants in Spain(ES).
Roche and Johnson & Johnson could be the strongest competitors for Zhangzhou Pien Tze Huang Pharmaceutical
For comprehensive analysis of Zhangzhou Pien Tze Huang Pharmaceutical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
